February 14, 2014

Improving breast cancer outcomes: FDG PET peers in on adrenoceptor blockers

Adrenoceptor blockers have been found to stave off metastasis and recurrence of breast cancer. This may be due to their interruption of key genes involved in glucose metabolism as visualized by FDG-PET, according to a study published Feb. 6 in the Journal of Nuclear Medicine. {read more here}